1. NinePoint Medical to Present NvisionVLE Clinical Data at Digestive Disease Week 2013

    NinePoint Medical to Present NvisionVLE Clinical Data at Digestive Disease Week 2013

    NinePoint Medical, Inc., an emerging leader in the development of medical devices for in vivo imaging, today announced that new clinical data on its proprietary NvisionVLE Imaging System will be featured in five poster presentations during Digestive Disease Week (DDW) taking place May 18-21, 2013, in Orlando, Fla. In addition, researchers from Massachusetts General Hospital (MGH) will highlight the core imaging technology of NvisionVLE, as well as a follow-on confocal endomicroscopy system, in two oral and two poster presentations. NinePoint licensed the imaging technology from MGH in 2010 as part of the largest intellectual property agreement for medical device technology in the hospital’s history.

    The schedule for oral and poster presentations related to advanced optical coherence tomography (OCT) and NvisionVLE at DDW 2013 is as follows:

    Date/Time:

     

    Sunday, May 19, 8 a.m. (ET)

    Abstract Title:

     

    Can Volumetric Laser Endomicroscopy Detect Dysplasia in Barrett’s Esophagus?

    Session/Location:

     

    ASGE Posters Esophagus, Orange County Convention Center, Hall West A1

       

     

    Date/Time:

     

    Sunday, May 19, 2 p.m. (ET)

    Abstract Title:

     

    Volumetric Microscopy Biopsy Guidance Platform for Barrett’s Esophagus: A Pilot Study

    Session/Location:

     

    Integration of Endoscopic Assessment of Morphological and Functional Features of Upper GI Diseases, Orange County Convention Center, 204

       

     

    Date/Time:

     

    Sunday, May 19, 2:45 p.m. (ET)

    Abstract Title:

     

    Tethered Capsule Endomicroscopy for Barrett’s Esophagus Screening

    Session/Location:

     

    Integration of Endoscopic Assessment of Morphological and Functional Features of Upper GI Diseases, Orange County Convention Center, 204

       

     

    Date/Time:

     

    Monday, May 20, 8 a.m. (ET)

    Abstract Title:

     

    Comparison of Volumetric Laser Endomicroscopy and Endoscopic Confocal Laser Endomicroscopy for the Detection of Dysplasia in Barrett’s Esophagus

    Session/Location:

     

    ASGE Posters New Technology – Diagnosis/Imaging and NOTES, Orange County Convention Center, Hall West A1

       

     

    Date/Time:

     

    Monday, May 20, 8 a.m. (ET)

    Abstract Title:

     

    Comprehensive Esophageal Cellular Imaging with Spectrally-encoded Confocal Endomicroscopy

    Session/Location:

     

    ASGE Posters New Technology – Diagnosis/Imaging and NOTES, Orange County Convention Center, Hall West A1

       

     

    Date/Time:

     

    Monday, May 20, 8 a.m. (ET)

    Abstract Title:

     

    Development of a Confocal Endomicroscopy Capsule for Diagnosis of Eosinophilic Esophagitis

    Session/Location:

     

    New insights into the Diagnosis and Treatment of Barrett’s Esophagus, Orange County Convention Center, Hall West A1

       

     

    Date/Time:

     

    Monday, May 20, 8 a.m. (ET)

    Abstract Title:

     

    Thickness of Neosquamous Epithelium is Associated with Response to Radiofrequency Ablation

    Session/Location:

     

    New insights into the Diagnosis and Treatment of Barrett’s Esophagus, Orange County Convention Center, Hall West A1

       

     

    Date/Time:

     

    Monday, May 20, 8 a.m. (ET)

    Abstract Title:

     

    Volumetric Laser Endomicroscopy Dysplasia Criteria in Barrett’s Esophagus: Expert versus Non-expert Agreement

    Session/Location:

     

    ASGE Posters New Technology – Diagnosis/Imaging and NOTES, Orange County Convention Center, Hall West A1

       

     

    Date/Time:

     

    Tuesday, May 21, 8 a.m. (ET)

    Abstract Title:

     

    Feasibility of Using a Novel Imaging Technique in Patients with Barrett’s Esophagus: 3 Dimensional Volumetric Laser Endomicroscopy

    Session/Location:

     

    Confocal and Enhanced Endoscopic Imaging, Orange County Convention Center, Hall West A1

       

     

    For a demonstration of the NvisionVLE Imaging System at DDW 2013, please visit NinePoint Medical at booth #1434.

    About NinePoint Medical, Inc.

    NinePoint Medical, Inc. is a transformational medical device company developing innovative, real-time, in vivo imaging devices focused on dramatically improving patient care. The proprietary NvisionVLE™ Imaging System will enable physicians and pathologists, for the first time, to view real-time, high-resolution, volumetric images of esophageal tissue up to 3mm deep at better than 10 micron resolution. NinePoint is preparing for a commercial launch of the NvisionVLE Imaging System in the U.S. in May 2013. The NvisionVLE Imaging System is indicated for use as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization. The safety and effectiveness of this device for diagnostic analysis (i.e. differentiating normal versus specific abnormalities) in any tissue microstructure or specific disease has not been evaluated. Headquartered in Cambridge, Mass., NinePoint is backed by Third Rock Ventures and Prospect Venture Partners. For more information, please visit www.ninepointmedical.com. 

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics Mentioned

  3. Authors